2018
DOI: 10.1016/j.msec.2018.06.046
|View full text |Cite
|
Sign up to set email alerts
|

Vasorelaxant effect of standardized extract of Cecropia glaziovii Snethl encapsulated in PLGA microparticles: In vitro activity, formulation development and release studies

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
5
0
1

Year Published

2019
2019
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(7 citation statements)
references
References 28 publications
1
5
0
1
Order By: Relevance
“…The antihypertensive effect of C. glaziovii has demonstrated in rats with an aqueous extract, and the mechanism of action on animals was not due to ACE inhibition or nitric oxide (NO) synthesis but generated long-term hypotension in an l-NAME model of hypertension [22,23]. This antihypertensive effect could be explained by a vasorelaxant action promoted by a hydroethanolic extract obtained from the leaves of C. glaziovii, which was endothelium-dependent, confirming the need for endothelial factors to observe the phenomenon [24]. Extract from C. glaziovii has a bronchodilator effect, as demonstrated by Delarcina et al, which inhibits bronchospasm histamine-induced in guinea pigs after treatment with aqueous extract or semi-purified fractions [25].…”
Section: Daga Et Almentioning
confidence: 89%
“…The antihypertensive effect of C. glaziovii has demonstrated in rats with an aqueous extract, and the mechanism of action on animals was not due to ACE inhibition or nitric oxide (NO) synthesis but generated long-term hypotension in an l-NAME model of hypertension [22,23]. This antihypertensive effect could be explained by a vasorelaxant action promoted by a hydroethanolic extract obtained from the leaves of C. glaziovii, which was endothelium-dependent, confirming the need for endothelial factors to observe the phenomenon [24]. Extract from C. glaziovii has a bronchodilator effect, as demonstrated by Delarcina et al, which inhibits bronchospasm histamine-induced in guinea pigs after treatment with aqueous extract or semi-purified fractions [25].…”
Section: Daga Et Almentioning
confidence: 89%
“…PLGA-MH microspheres were prepared using a modified double emulsion (w1/o/w2) solvent extraction/evaporation technique (dos Santos et al, 2018). Briefly, 150 mg of MH were solubilized in 500 μL of distilled water (internal aqueous phase, w1), and added to 5 mL of dichloromethane containing 500 mg of PLGA (oil phase, o).…”
Section: Preparation Of Plga-mh Microspheresmentioning
confidence: 99%
“…Then, it was filled with approximately 200 mg of microspheres, suspended in 50 mL of phosphate buffer pH 6.8 (release medium), and maintained in a thermostatic water bath with magnetic stirring (DI-06, Dist, Brazil) at 37 °C and 150 rpm. At predetermined time intervals, 1 mL of the release medium was withdrawn and replaced with the same volume of fresh medium (dos Santos et al, 2018). The MH concentration in each aliquot was quantified in a UV-Vis spectrophotometer (UV-1800, Shimadzu, Japan) at 232 nm.…”
Section: In Vitro Mh Release From Plga Microspheresmentioning
confidence: 99%
“…Other promising applications include the further study of Cglycosyl flavonoid enriched fraction of C. glaziovii-loaded nanospheres and standardized hydroethanolic C. glaziovii-loaded PLGA microparticles as drug delivery systems to treat labial herpes and hypertension [117][118][119]. In these investigations, the developed particle preparations were proposed to be capable of overcoming the bioavailability, permeability, and solubility issues associated with flavonoids [118,119]. Additionally, a magnetic emulsion nanoparticle of maghemite dispersed in an aqueous extract of C. obtusifolia leaves provided long-term biocompatibility and chemical stability to the extract [120].…”
Section: Future Perspectivesmentioning
confidence: 99%